In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …

We conducted a serological study to define correlates of immunity against SARS-CoV-2.
Compared to those with mild coronavirus disease 2019 (COVID-19) cases, individuals with …

Since December 2019, the novel coronavirus, SARS-CoV-2, has garnered global attention
due to its rapid transmission, which has infected more than two million people worldwide …

It has been more than a year since severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) first emerged. Many studies have provided insights into the various aspects of the …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) caused outbreaks of
the pandemic starting from the end of 2019 and, despite ongoing vaccination campaigns …

Abstract Development of antibody protection during SARS-CoV-2 infection is a pressing
question for public health and for vaccine development. We developed highly sensitive …

The 2003 severe acute respiratory syndrome coronavirus (SARS-CoV-1) causes more
severe disease than SARS-CoV-2, which is responsible for COVID-19. However, our …

Understanding antibody responses to SARS-CoV-2 is indispensable for the development of
containment measures to overcome the current COVID-19 pandemic. Recent studies …

Background COVID-19 has caused more than 2.6 billion infections and several million
deaths since its outbreak 2 years ago. We know very little about the long-term cellular …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that poses a great threat to …